These results suggest that mild to moderate hyperglycemia is required for the insulinotropic effect of GIP in nondiabetic subjects, acting as a mechanism to prevent reactive hypoglycemia following the consumption of fatty foods
In contrast, injectable semaglutide is usually started at a dose of 0.25 mg once weekly for the first month, gradually increasing to 0.5 mg to 1.0 mg weekly over time to achieve a maintenance dose
Remember, these are general nutrition considerations to keep in mind while you are on a GLP-1 weight-loss medication
Overdose can induce severe nausea, vomiting, dehydration, or low blood sugar, necessitating immediate medical attention
A few changes in the world of GLP-1 agonists are making the drugs more accessible to people, even if their health care plans don't cover them